Education

Novo Nordisk reduces its U.S. sales team for obesity and diabetes education: Reuters

Novo Nordisk reduces its U.S. sales team for obesity and diabetes education: Reuters

Sep. 18, 2025 4:14 PM ETNovo Nordisk A/S (NVO) StockLLYBy: Nilanjana Basu, SA News Editor
Comments
Novo Nordisk (NVO) has laid off its U.S. sales team focused on obesity and diabetes education for healthcare providers, known as cardiometabolic educators, as part of broader restructuring under new CEO Maziar Mike Doustdar, Reuters said in a report.
The
Recommended For You
More Trending News
About NVO Stock
SymbolLast Price% Chg
1D
5D
1M
6M
1Y
5Y
10Y
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Related Stocks
SymbolLast Price% ChgNVO–Novo Nordisk A/S
Trending Analysis
Trending News